Company Profiles

driven by the PitchBook Platform

Appili Therapeutics

Appili Therapeutics
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$400k LATEST DEAL AMOUNT
$4.88M TOTAL AMOUNT RAISED
Description

Developer of novel therapeutics created for the treatment of infectious diseases. The company's novel therapeutics are oral antibiotics addressed for existing critical unmet medical needs like anaerobic infections, enabling patients with infectious diseases to get treated for the most drug-resistant infections.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
No. 21-1344 Summer Street
Halifax, Nova Scotia B3H 0A8
Canada

+1 (902) 442-4655 x5
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Appili Therapeutics’s full profile, request a free trial.

Appili Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 11-Apr-2017 $400k $4.88M Completed Product Development
6. Grant 17-Feb-2017 00.00 00.000 Completed Product Development
5. Seed Round 15-Dec-2016 00.000 00.000 Completed Product Development
4. Seed Round 25-May-2016 00.000 00.000 Completed Startup
3. Grant 10-Aug-2015 0000 Completed Startup
2. Seed Round 01-Jan-2015 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Appili Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Atlantic Canada Opportunities Agency Government Minority 000 0000 000000 0
BioNova Accelerator/Incubator Minority 000 0000 000000 0
Bloom Burton & Co. Other Minority 000 0000 000000 0
Innovacorp Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Appili Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Kevin Sullivan Chief Executive Officer & Board Member
Kimberly Stephens Chief Financial Officer
Jamie Doran Director, Drug Development

You’re viewing 3 of 3 executives.

Appili Therapeutics Board Members (5)

Name Representing Role Since Contact
Info
Brian Bloom Bloom Burton & Co. Chairman of the Board 000 0000
John Holyoake Ph.D Bloom Burton & Co. Board Member 000 0000
Kevin Sullivan Appili Therapeutics Chief Executive Officer & Board Member 000 0000
Lidija Marusic Ph.D Innovacorp Board Member 000 0000
Stephen Nicolle Self Board Member 000 0000

You’re viewing 5 of 5 board members.